ClearPoint Neuro (CLPT) CFO acquires 1,085 shares through ESPP

Rhea-AI Filing Summary

ClearPoint Neuro Chief Financial Officer Danilo D'Alessandro acquired 1,085 shares of common stock through the company’s Employee Stock Purchase Plan. The shares relate to the ESPP purchase period from January 1, 2026 through June 30, 2026 and were bought at $11.93 per share. After this routine compensation-related acquisition, he directly holds 103,769 shares of ClearPoint Neuro common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider D'Alessandro Danilo

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,085	$11.93	$13K

Holdings After Transaction: Common Stock — 103,769 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

ESPP shares acquired: 1,085 shares Acquisition price: $11.93 per share Shares held after transaction: 103,769 shares +1 more

4 metrics

ESPP shares acquired 1,085 shares Common Stock acquired under ESPP for period Jan 1–Jun 30, 2026

Acquisition price $11.93 per share Price for ESPP acquisition on June 30, 2026

Shares held after transaction 103,769 shares Direct holdings of CFO after ESPP acquisition

ESPP discount mechanism 85% of fair market value Lesser of first or last day price for Jan 1–Jun 30, 2026 period

Key Terms

Employee Stock Purchase Plan, ESPP, fair market value, Form 4

4 terms

Employee Stock Purchase Plan financial

"The reporting person is voluntarily reporting the acquisition of the Issuer's common stock pursuant to the Employee Stock Purchase Plan ("ESPP")"

An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.

ESPP financial

"pursuant to the Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of January 1, 2026 through June 30, 2026"

An Employee Stock Purchase Plan (ESPP) is a company program that lets employees buy the company’s shares at a reduced price, usually by setting aside a small portion of their pay over time. It matters to investors because it encourages employees to own part of the business—like giving staff a discounted membership— which can boost commitment and performance, while also potentially increasing the number of shares available and affecting shareholder value.

fair market value financial

"shares were purchased at the lesser of 85% of the fair market value on either the first day or last day of the purchase period"

The price a willing buyer and a willing seller would agree on for an asset or security when neither is under pressure and both have access to the same information. Think of it as the market’s neutral estimate of what something is worth, like the price two neighbors would settle on for a car after comparing similar listings. Investors care because fair market value guides buying and selling decisions, tax reporting, portfolio valuation, and how accurately company assets are reflected in financial statements.

Form 4 financial

"The reporting person is voluntarily reporting the acquisition of the Issuer's common stock pursuant to the Employee Stock Purchase Plan"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/02/2026 - 04:06 PM Accepted by SEC EDGAR 07/02/2026 - 04:05 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

D'Alessandro Danilo

(Last) (First) (Middle)

C/O CLEARPOINT NEURO, INC.

120 S. SIERRA AVE., SUITE 100

(Street)

SOLANA BEACH CALIFORNIA 92075

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ClearPoint Neuro, Inc. [ CLPT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/30/2026		A		1,085	A	$11.93(1)	103,769	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reporting person is voluntarily reporting the acquisition of the Issuer's common stock pursuant to the Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of January 1, 2026 through June 30, 2026. In accordance with the ESPP, these shares were purchased at the lesser of 85% of the fair market value on either the first day or last day of the purchase period.

	/s/ Danilo D'Alessandro	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did ClearPoint Neuro (CLPT) report for its CFO?

ClearPoint Neuro’s CFO, Danilo D'Alessandro, reported acquiring 1,085 shares of common stock. The shares were obtained through the Employee Stock Purchase Plan for the January 1 to June 30, 2026 purchase period, reflecting a routine, compensation-related stock acquisition rather than an open-market trade.

At what price did the ClearPoint Neuro (CLPT) CFO acquire ESPP shares?

The CFO’s 1,085 shares were acquired at $11.93 per share. According to the plan, ESPP purchases occur at 85% of the lower fair market value on the first or last day of the January 1 to June 30, 2026 purchase period, providing a standard employee discount.

How many ClearPoint Neuro (CLPT) shares does the CFO hold after this Form 4?

Following the ESPP acquisition, the CFO directly holds 103,769 shares of ClearPoint Neuro common stock. This total includes the newly purchased 1,085 shares from the January 1 to June 30, 2026 Employee Stock Purchase Plan period, as reported in the Form 4 filing.

Was the ClearPoint Neuro (CLPT) CFO’s acquisition an ESPP transaction or open-market buy?

The acquisition was executed under ClearPoint Neuro’s Employee Stock Purchase Plan, not as an open-market purchase. Shares for the January 1 to June 30, 2026 period were bought at 85% of the lower fair market value on the first or last day of that period.

What does the Employee Stock Purchase Plan mean for ClearPoint Neuro (CLPT) insiders?

The Employee Stock Purchase Plan allows eligible insiders to buy ClearPoint Neuro shares at a discount. For the January 1 to June 30, 2026 period, the CFO acquired shares at 85% of the lower fair market value on the first or last day, aligning incentives with shareholders.